MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务。

CYM-5478

CAS No. : 870762-83-7

MCE 站：CYM-5478

产品活性：CYM-5478 是一种有效，高度选择性的 S1P₂ 激动剂，在TGFα-脱落试验中 EC₅₀ 为119? nM。CYM-5478 保护神经衍生细胞系免受顺铂 (Cisplatin) 毒性。

研究领域：GPCR/G Protein

作用靶点：LPL Receptor

In Vitro: CYM-5478 activates S1P₂ with an EC₅₀ of 119?nM, has less than 25% efficacy and shows 10-fold lower potency against the other S1P receptor subtypes (EC₅₀ of 1690 nM, 1950 nM, >10 μM, >10 μM for S1P₁, S1P₃, S1P₄, S1P₅, respectively).
CYM-5478 (1, 10, 100, 1000, 10000 nM) induces a statistically significant increase in the viability of C6 cells in a dose dependent manner at concentrations above 100?nM under nutrient-deprivation stress produced by serum-starvation. This effect was absent in the presence of 10% fetal bovine serum.
CYM-5478 (10?μM) causes a statistically significant, 3-fold increase in the EC₅₀ of Cisplatin-mediated reduction in the viability of C6 glioma cells. CYM-5478 also attenuated Cisplatin-induced caspase 3/7 activity.
CYM-5478 (10?μM) causes significantly attenuated the increase of ROS in C6 cells exposed to Cisplatin (20?μM; for 24?hours).
CYM-5478 (20 μM) protects neural cells but not breast cancer cells against Cisplatin toxicity (C6 glioma cells: EC₅₀=4.54 μM; GT1-7: EC₅₀=17 μM; SK-N-BE2: EC₅₀=7.44 μM; CLU188: EC₅₀=5.54 μM).

In Vivo: CYM-5478 (1 mg/kg/day; ip) protects against Cisplatin-mediated (3 mg/kg; i.p.; once a week for 3 week) ototoxicity in rats.
CYM-5478 (20 μM) treatment results in near-complete protection from cisplatin-mediated loss of neuromast viability. CYM-5478 protects against loss of hair cell viability in a zebrafish model for ototoxicity.

相关产品：Fingolimod hydrochloride  |  PF-543 Citrate  |  Siponimod  |  Ozanimod  |  JTE-013  |  BMS-986020  |  Ki16425  |  TY-52156  |  Sphingosine-1-phosphate  |  AM095  |  Ponesimod  |  SEW?2871  |  Etrasimod  |  1-Oleoyl lysophosphatidic acid  |  AS2717638  |  FTY720 (S)-Phosphate  |  LPA2 antagonist 1  |  CYM-5541  |  Cenerimod  |  AM966  |  Ceranib-2  |  ONO-7300243  |  Amiselimod hydrochloride  |  CYM50308  |  GSK2018682  |  ASP6432  |  CYM50260

热门产品线：重组蛋白  |  化合物库  |  天然产物  |  染料试剂  |  PROTAC  |  同位素标记物

Trending products：Recombinant Proteins  |  Bioactive Screening Libraries  |  Natural Products  |  Dye Reagents  |  PROTAC  |  Isotope-Labeled Compounds

品牌介绍:
•   MCE (MedChemExpress) 拥有数百种全球独家化合物，我们致力于为全球科研客户提供*新*全的高品质小分子活性化合物；
•   10,000 多种高选择性抑制剂、激动剂涉及各热门信号通路及疾病领域；
•   设有专业的实验中心和严格的质控、验证体系；
•   提供 LC/MS、NMR、HPLC、手性分析、元素分析等各项质检报告，确保产品的高纯度、高品质；
•   产品的生物活性多经各国客户实验验证；
•   Nature, Cell, Science 等多种期刊及制药收录了MCE客户的科研成果；
•   专业团队跟踪*新的制药及生命科学研究进展，为您提供全球*新的活性化合物；
•   与世界各大制药公司及知名科研机构建立了长期的合作。